Net Income

The indoor air quality giant launches its roadshow, seeking to pay down debt and capitalize on soaring demand for healthier buildings and AI infrastructure.

Vyome is set to present promising Phase 2 data for VT-1953, a first-in-class treatment for a debilitating cancer complication with no approved drugs.

In a pivotal move from R&D to commercial scale, Zivo Bioscience partners with industry leader Cyanotech to meet global demand for its unique algal biomass.

CanTex Capital's landmark sale of a 1.3M sq ft portfolio to Partners Group highlights booming demand for DFW's strategic shallow bay industrial assets.

New data shows companies working with CEO Coaching International are seeing revenue and profit growth that nearly doubles and triples U.S. market averages.

Boston's Bio-IT World conference shifts from AI theory to execution, showcasing how the life sciences industry is now deploying AI to accelerate new therapies.

Amid financial headwinds, radiation therapy firm Accuray appoints a proven sales leader to spearhead a critical commercial transformation.

At AAN 2026, SK Life Science will present new cenobamate data and survey findings that expose a critical communication gap in epilepsy care.

A long-acting ketamine injection shows promise in treating severe depression without the harsh side effects and monitoring, potentially expanding access for millions.

New preclinical data for ATNM-400 and Actimab-A shows promise for treating resistant solid tumors and AML, highlighting a new frontier in cancer therapy.

MTI replaces its Road Tour with an intense, invite-only forum, uniting top regulators and experts to find the next wave of healthcare solutions.

Malaysia's Universiti Teknologi PETRONAS has surged into the world's top 10 for Petroleum Engineering, but what does this mean in a transitioning world?

Sigma Nursing and Johnson & Johnson launch a new, free program to equip nurses with psychological tools for disaster response, aiming to combat burnout.

As PharmaCorp Rx prepares for a key investor conference, its strategy of consolidating independent pharmacies faces a pivotal test of market confidence.

The materials tech firm gets a major vote of confidence from top banks, extending its financial runway to 2030 to fund growth and manage recent debt.

As 'forever chemicals' plague South Florida, a new, costly plasma exchange therapy offers a solution. But is it a medical breakthrough or a luxury trend?

After a years-long fight, a major airline caterer admits to violating worker rights, settling a key NLRB case and revealing a pattern of abuses.

Service Properties Trust raised over half a billion dollars in a massive share offering, paying down debt but causing extreme dilution for its investors.

Biopharma firm GENFIT sees soaring Iqirvo sales and a cash runway past 2028, overshadowing a net loss driven by strategic, non-cash write-downs.

MetLife Investment Management hires Andrea Drasites from Blackstone to head its real estate arm, a strategic move to scale after its PineBridge acquisition.